A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Conditions
Advanced Solid Tumors · Genital Neoplasm, Female · Urogenital Neoplasms · Lung Neoplasm · Neoplasms by Site · Papillomavirus Infection · Epstein-Barr Virus Infections · Carcinoma · Neoplasms · Vulvar Neoplasms · Vulvar Diseases · Abdominal Neoplasm
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Loma Linda University Cancer Center, Loma Linda, California, United States
Contact: Principal Investigator (John Shin, MD)UC Davis Comprehensive Cancer Center, Sacramento, California, United States
Contact: Principal Investigator (Tianhong Li, MD)Sarah Cannon Research Institute at HealthONE, Denver, Colorado, United States
Contact: Principal Investigator (Jason Henry, MD)AdventHealth Celebration, Celebration, Florida, United States
Contact: Principal Investigator (Guru Sonpavde, MD)University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States
Contact: Principal Investigator (Marijo Billusic, MD)The University of Kansas Cancer Center, Kansas City, Kansas, United States
Contact: Principal Investigator (Weijing Sun, MD)National Institutes of Health, Bethesda, Maryland, United States
Contact: Principal Investigator (James Gulley, MD, PhD)Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
Contact: Principal Investigator (Ryan Sullivan, MD)Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (Ann Silk, MD)Karmanos Cancer Institute, Detroit, Michigan, United States
Contact: Principal Investigator (Wasif Saif, MD)Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Contact: Principal Investigator (Gopa Iyer, MD)The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Contact: Principal Investigator (Kai He, MD)University of Oklahoma Health Sciences, Stephenson Cancer Center, Oklahoma City, Oklahoma, United States
Contact: Principal Investigator (Abdul R Naqash, MD)Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville), Nashville, Tennessee, United States
Contact: Principal Investigator (Meredith Pelster, MD)The University of Texas, MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Stephane Champiat, MD)UT Health Mays Cancer Center, San Antonio, Texas, United States
Contact: Principal Investigator (Sukeshi Patel Arora, MD)Fred Hutchinson Cancer Center, Seattle, Washington, United States
Contact: Principal Investigator (Diane Tseng, MD)University of Wisconsin- Madison, Madison, Wisconsin, United States
Contact: Principal Investigator (Vincent Ma, MD)Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Contact: Principal Investigator (Lillian Siu, MD)Research Institute of McGill University Health Centre, Montreal, Quebec, Canada
Contact: Principal Investigator (Ramy Saleh, MD)Hopsital Institut Curie, Paris, France, France
Contact: Principal Investigator (Christophe Le Tourneau, MD, PhD)Oncopole Claudius Regaud IUCT, Toulouse, France, France
Contact: Principal Investigator (Carlos Gomez-Roca, MD)Institut Bergonié, Bordeaux, France
Contact: Principal Investigator (Antoine Italiano, MD)Centre Leon Berard, Lyon, France
Contact: Principal Investigator (Philippe Cassier, MD)Institute Gustave Roussy, Villejuif, France
Contact: Principal Investigator (Aurelien Marabelle, MD)Vall d'Hebron Institute of Oncology, Barcelona, Catalonia, Spain
Contact: Principal Investigator (Elena Garralda, MD)Clinica Universidad de Navarra, San Blas-Canillejas, Madrid, Spain
Contact: Principal Investigator (Eduardo Castanon, MD)Hospital Universitario Quirónsalud Madrid, Madrid, Spain, Spain
Contact: Principal Investigator (Valentina Boni, MD)NEXT Oncology Barcelona, Hospital Quirónsalud Barcelona, Barcelona, Spain
Contact: Principal Investigator (Omar Saavedra, MD)START Madrid FJD, Madrid, Spain
Contact: Principal Investigator (Manuel Pedregal, MD)Clinica Universidad de Navarra, Pamplona, Spain
Contact: Principal Investigator (Eduardo Castanon, MD)Instituto de Investigacion Sanitaria, INCLIVA, Valencia, Spain
Contact: Principal Investigator (Susana Roselló, MD)